Eggerthella lenta is rarely isolated from blood but may occur as an opportunistic pathogen with high morbidity and mortality. We report a case of E. lenta bacteremia after an endoscopic retrograde cholangiopancreatography in an end-stage renal disease patient. (Ann Clin Microbiol 2014;17:128-131)
INTRODUCTION
Many anaerobic Gram-positive bacilli including Clostridium, Propionibacterium, and Eggerthella are common gut commensals [1, 2] . Many of these bacteria are considered as contaminants in blood culture, but some Eggerthella species isolated from blood culture are clinically significant [3] . In particular, Eggerthella lenta is rarely isolated from blood but may occur as an opportunistic pathogen with high morbidity and mortality. The first Korean case report of E. lenta bacteremia was presented in 2014 [4] . Herein, we report a case of E. lenta bacteremia after endoscopic retrograde cholangiopancreatography (ERCP) in an end-stage renal disease patient.
CASE REPORT
A 69-year-old man visited our emergency room with abdominal pain of one day. In past medical history, he had a surgery for mitral and tricuspid valve prolapse 19 years ago. He was diagnosed with liver cirrhosis and end-stage renal disease 12 years ago, and then has taken hemodialysis since then. In addition, he had a surgery for common bile duct stone with cholangitis 10 years ago. On physical examination, he had tenderness on epigastrium, a blood pressure of 90/60 mmHg, heart rates of 120 beats/min, and a respiratory rate of 22 breaths/min. His initial blood cell counts were as follows: hemoglobin, 12.7 g/dL; white blood cell counts, 15.4×10 Lactobacillus, and Actinomyces [1, 7] . Although some automated identification systems such as Vitek 2, have E. lenta in their databases, these tests are limited. Furthermore, most databases of commercial rapid identification systems do not include new subspecies of Eggerthella, Paraeggerthella, and Eubacterium [7] .
Because of this limitations, 16S rRNA sequencing is thought as a good choice for a diagnostic tool to confirm E. lenta infections [2, 6, 8] . And E. lenta bacteremia is considered to be more than identified because of its difficulties of identification [2, 8] . But in the case of E. lenta from VITEK 2, we think that confirmation by 16S rRNA sequencing may not be needed in consideration of latest reports including our case [4, 6, 9] . E. lenta was isolated from feces primarily and known as gut commensals. The various cases of E. lenta infections were reported associated with intrauterine devices, bacteremia associated with malignancy and female genital tract infections [10] , cutaneous abscess [11] and bacteremia in Crohn's disease patient [9] . Some reports showed that E. lenta can lead to high morbidity and mortality including septic shock, multiple organ failure, and death [7, 9] , but the pathogenesis of these cases, especially bacteremia, has not been well established [2, 7, 9, [12] [13] [14] .
We hypothesize that translocation from gut to blood may be possible if there are defects in the gastrointestinal tract, because E. lenta is known to be a gut commensal [9] . Also a group in Hong Kong also reported that 18% of clinically significant bacteremia caused by anaerobic, gram-positive bacilli were related to E. lenta [2] . Furthermore, E. lenta bacteremia is primarily community acquired [2, 3] .
In our case, the patient had E. lenta bacteremia after ERCP.
Therefore, E. lenta bacteremia could be secondary infection due to translocation into blood from GI tract after ERCP and ENBD.
The patient had acute cholecystitis with combined mild hepatocholangitis and the known predisposing factor of end-stage renal disease treated by hemodialysis. Other known predisposing factors include malignancy, immobilization, bed sores, diabetes mellitus, and stroke [2, 7] .
We are not sure that the B. vulgatus isolated before ERCP was primary pathogen in biliary sepsis, but there are many mixed infection by anaerobic bacteria and we cannot recover B.
vulgatus from second drawn of blood culture that E. lenta isolated from. So we think there are two possibilities. First, it was transient bacteremia or contaminant without clinical significance because we could not isolate it from second drawn blood culture. Second, the B. vulgatus bacteremia was true pathogen before ERCP and no growth in second drawn of blood cultures due to empirical injection of flumoxef sodium, but we thought it was less likely.
Bacteremia caused by anaerobic, gram-positive bacilli should be managed cautiously. Especially in patients with predisposing factors, bacteremia is associated with high mortality [3, 6, 7, 14] .
Exact identification of the infection source and causal organism should be sought, and prompt initiation of antibiotic treatment is needed. E. lenta and some anaerobic bacteria can be identified using commercial identification systems. As mentioned above, we think E. lenta identification from VITEK 2 may be reliable but more studies about the identification of anaerobes and its confirmation is needed.
A few studies reported the susceptibilities of E. lenta [3, 6, 7, 15] . In the article by Mosca et al, including 29 strains of E. lenta clinical isolated, all were susceptible to clindamycin, piperacillin and imipenem [15] . And Lau et al. reported all 10
Eggerthella and Paraeggerthella isolates were susceptible to penicillin and metronidazole [3] . But another study by Lee et al., they reported 8 strains of E. lenta clinical isolated showed high resistance rate to penicillin but all of the tested strains showed susceptible to ampicillin-sulbactam, meropenem, imipenem and metronidazole. Also they performed the susceptibility tests of the newly developed antibiotics including doripenem, tigecycline and daptomycin and they showed low MICs [7] . This result reported in 2012 was different with the report by Lau et al in 2004 about the susceptibility to penicillin. We think susceptibility to penicillin may be decreased due to antibiotics overuse. So we suggest that clinicians should avoid the use of penicillin in the case of E. lenta bacteremia because recent report showed high resistance to penicillin [7] . We think metronidazole may be first choice for E. lenta bacteremia according to previous reports and carbapenems could be used, too. We cannot find ertapenem breakpoint and did not perform the susceptibility test of ertapenem, but there is an interesting case report that showed clinical improvement using ertapenem empirically [12] .
This case illustrates that E. lenta bacteremia can be caused by invasive procedures through the intestines in patients with predisposing risk factors. The conventional phenotype method of diagnosis for anaerobic, gram-positive bacteremia may be confirmed by 16S rRNA gene sequencing. Since E. lenta bacteremia shows high mortalities, clinicians should manage the bacteremia carefully.
